Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Liberia: 8 Hospital Staff Under Observation in Ebola Scare

By Drug Discovery Trends Editor | February 23, 2015

Eight health workers at a hospital in Liberia’s capital have been sent home for observation after coming into contact with a patient who later tested positive for Ebola, the country’s assistant health minister said Saturday.
 
The incident occurred at the S.D. Cooper Hospital in Monrovia’s Sinkor neighborhood, Tolbert Nyenswah said. The patient, a woman, was transferred to the hospital from a smaller hospital, and staff began treating her before an Ebola test was conducted, Nyenswah said.
 
The health workers will be under observation for 21 days and will not be coming into work during that period, he said.
 
“You cannot be under observation and then at the same time go to work to expose people. No way,” he said.
 
There are now eight patients who have tested positive for Ebola being cared for at treatment centers in Liberia, Nyenswah said. Seven of those are in Monrovia, while another is in the town of Kakata, 35 miles northeast of the capital.
 
That total is a far cry from last year when the West African nation was the center of the worst Ebola outbreak in history.
 
Liberia has recorded more than 9,000 confirmed, suspected and probable Ebola cases and 3,900 deaths, according to the World Health Organization. However, WHO’s most recent update reported only two new cases in the previous week, and schools began reopening earlier this week.
 
On Friday, President Ellen Johnson Sirleaf ordered officials to lift a curfew put in place six months ago and to reopen the country’s land border crossings.
 
Sirleaf is preparing to meet with President Barack Obama next week at the White House. In an interview with state radio, she said she hopes to resume overseas travel after months of staying in Liberia and focusing on the outbreak.
 
“I feel that I can now take a little bit of a break. But that break is also work-related,” she said, noting that she also planned to speak about Ebola at a conference in Brussels in March.

Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE